China halts track-and-trace project because of complaints against Alibaba

China's FDA has put a moratorium on an electronic drug tracking system after a lawsuit was filed alleging that Hong Kong-listed Alibaba Health Information Technology, or Ali Health, which is designing it, was gaining an unfair trade advantage over other drug sellers. The Alibaba Group last year moved to get a controlling stake in Ali Health in hopes that online drug sales will be approved. At the same time, it has been working on offering online over-the-counter sales. More from FiercePharmaAsia

Suggested Articles

McCallum was hit with a warning letter from the FDA for testing issues with its products and failing to keep appropriate records.

The FDA made public a voluntary recall of sterile injectables made by Coastal Meds of Mississippi, after visible particles were found in some vials.

It’s been a strange road for BMS' Opdivo-Yervoy combo in first-line kidney cancer, but the New Jersey drugmaker finally has a go-ahead.